Amathus Therapeutics logo

Amathus Therapeutics

Amathus Therapeutics is developing first-in-class, small-molecule therapeutics designed to enhance mitochondrial function, which have the potential to treat neurodegenerative diseases, such as Parkinson’s disease, and lysosomal-storage disorders — rare, but devastating inherited metabolic diseases that are characterized by an abnormal build-up of various toxic materials in the body's cells as a result of enzyme deficiencies.

KEY DETAILS

Website
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
700 Main Street, 2139
Cambridge
United States
Email
Contact Number
+1 617-863-3650